This report provides a complete quantitative data and qualitative analysis on the global market for Niacinamide. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Niacinamide was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Niacinamide is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Niacinamide, including the following market information:
Global Niacinamide Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Niacinamide Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Niacinamide Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Niacinamide Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)

Key market players
Major competitors identified in this market include Lonza Group AG, Koninklijke DSM, Bactolac Pharmaceutical Inc, Merck KGaA, BASF SE, Foodchem International Corporation, Evonik Industries AG, Jubilant Life Sciences Limited, Vertellus Specialties Inc, Fagron NV, Zhejiang NHU Company Ltd, Brother Enterprises Holding Co., Ltd, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Powder
Granular
Liquid

Based on the Application:
Human Nutrition
Pharmaceuticals
Animal Nutrition
Cosmeceuticals
Others